Primary Pulmonary Hypertension is behind multiple hospitalizations and pulmonary transplants. Even though its treatment has been advanced, many patients will not respond well. The PADN-CFDA randomized 128 patients, 63 received pulmonary denervation (PADN) and 65 went to the control group. Primary end point was 6-minute walk distance test at 6 months. The populations were similar,...
✔️ Pulmonary Valve – SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Scientific Sessions 👨🏫 Contents: 00:10 – How to select the type of THV in pulmonary valve – Dr. Juan Pablo Sandoval (MEX).
✔️ Live Case 2, Main Arena – SOLACI-SOCIME 2022 ✔️ SOLACI-SOCIME 2022 Video
Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress. In this case, consult the presentation by Dr. Jorge Cervantes Salazar, entitled “Surgical Pulmonary Valve Replacement”
Pulmonary thromboembolism (PTE) is the third most frequent cardiovascular disease, with an increasing prevalence over time. The stratification of these patients is paramount to decide their therapeutic approach, since there have been high mortality rates for certain subgroups. The European Society of Cardiology, in its latest guidelines (2019), classified the severity of PTE according to...
At 10 years of the Melody Investigational Device Exemption we can observe this device for transcatheter pulmonary valve replacement might be a lifetime fix, both to extend the useful life of previously implanted right ventricular outflow tract (RVOT) conduits or bioprosthetic pulmonary valves. Patient enrollment for the US Investigational Device Exemption study of the Melody...
The US Food and Drug Administration (FDA) has cleared the SAPIEN 3 valve with the Alterra adaptive pre-stent for implantation in pulmonary position. According to Edwards Lifesciences, this new system developed for pulmonary valve is capable of compensating a wide variety of sizes and morphologies of the right ventricular outflow tract, allowing for stable valve implantation....
We invite you to take part in SOLACI’s Symposium at the Heart Failure and Pulmonary Hypertension – VI International Summit 2021 together with SOLACI’s Chair Dr. Aníbal Damonte (ARG), SOLACI’s Treasurer Dr. Omar Santaera (ARG), and Dr. Marcio Montenegro (BRA), Vice Chair of SOLACI Sessions. Dra. Florencia Renedo (ARG) will also be there. The activity...
✔️ Watch again the Session on “Complex Pulmonary Hypertension and Aortic Endovascular Aneurysm” in the SOLACI-CACI 2021 Congress. 👨🏫 Program: SESSION I: Chronic Thromboembolic Pulmonary Hypertension 02:48 – Definition, epidemiology, diagnostic algorithm and pharmacological treatment. – Pedro Trujillo 16:27 – Invasive Endovascular Strategies in Chronic PTE: Pulmonary Angioplasty – Fabio Solano 30:13 – Surgical Thromboendarterectomy....
Watch Again our Webinar on “Percutaneous Implantation of PULSTA Pulmonary Valve. What You Need to Know”.